The hepatorenal syndrome

[71] ORNIPRESSIN IN THE TREATMENT OF FUNCTIONAL RENAL-FAILURE IN DECOMPENSATED LIVER-CIRRHOSIS - EFFECTS ON RENAL HEMODYNAMICS AND ATRIAL-NATRIURETIC-FACTOR [J]. GASTROENTEROLOGY, 1991, 101 (04) : 1060 - 1067

[72] HEPATIC DENERVATION ALTERS 1ST-PHASE URINARY SODIUM-EXCRETION IN DOGS WITH CIRRHOSIS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (04): : F664 - F671

[73] PROGNOSTIC VALUE OF ARTERIAL-PRESSURE, ENDOGENOUS VASOACTIVE SYSTEMS, AND RENAL-FUNCTION IN CIRRHOTIC-PATIENTS ADMITTED TO THE HOSPITAL FOR THE TREATMENT OF ASCITES [J]. GASTROENTEROLOGY, 1988, 94 (02) : 482 - 487

[74] TUMOR-NECROSIS-FACTOR-ALPHA - A MAJOR CONTRIBUTOR TO THE HYPERDYNAMIC CIRCULATION IN PREHEPATIC PORTAL-HYPERTENSIVE RATS [J]. GASTROENTEROLOGY, 1995, 108 (03) : 761 - 767

[75] Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) : 664 - 670

[76] ENDOTOXIN LEVELS MEASURED BY A CHROMOGENIC ASSAY IN PORTAL, HEPATIC AND PERIPHERAL VENOUS-BLOOD IN PATIENTS WITH CIRRHOSIS [J]. HEPATOLOGY, 1988, 8 (02) : 232 - 236

[77] BRACHIAL AND FEMORAL-ARTERY BLOOD-FLOW IN CIRRHOSIS - RELATIONSHIP TO KIDNEY DYSFUNCTION [J]. HEPATOLOGY, 1993, 17 (05) : 788 - 793

[78] Mathie RT, 1996, HEPATOLOGY, V23, P130

[79] Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS:: Results of a prospective, randomized, controlled clinical trial [J]. LIVER TRANSPLANTATION, 2000, 6 (03) : 277 - 286

[80] ELEVATED CIRCULATING PLASMA ENDOTHELIN-1 CONCENTRATIONS IN CIRRHOSIS [J]. JOURNAL OF HEPATOLOGY, 1993, 19 (02) : 285 - 290

[71] ORNIPRESSIN IN THE TREATMENT OF FUNCTIONAL RENAL-FAILURE IN DECOMPENSATED LIVER-CIRRHOSIS - EFFECTS ON RENAL HEMODYNAMICS AND ATRIAL-NATRIURETIC-FACTOR [J]. GASTROENTEROLOGY, 1991, 101 (04) : 1060 - 1067

[72] HEPATIC DENERVATION ALTERS 1ST-PHASE URINARY SODIUM-EXCRETION IN DOGS WITH CIRRHOSIS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (04): : F664 - F671

[73] PROGNOSTIC VALUE OF ARTERIAL-PRESSURE, ENDOGENOUS VASOACTIVE SYSTEMS, AND RENAL-FUNCTION IN CIRRHOTIC-PATIENTS ADMITTED TO THE HOSPITAL FOR THE TREATMENT OF ASCITES [J]. GASTROENTEROLOGY, 1988, 94 (02) : 482 - 487

[74] TUMOR-NECROSIS-FACTOR-ALPHA - A MAJOR CONTRIBUTOR TO THE HYPERDYNAMIC CIRCULATION IN PREHEPATIC PORTAL-HYPERTENSIVE RATS [J]. GASTROENTEROLOGY, 1995, 108 (03) : 761 - 767

[75] Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) : 664 - 670

[76] ENDOTOXIN LEVELS MEASURED BY A CHROMOGENIC ASSAY IN PORTAL, HEPATIC AND PERIPHERAL VENOUS-BLOOD IN PATIENTS WITH CIRRHOSIS [J]. HEPATOLOGY, 1988, 8 (02) : 232 - 236

[77] BRACHIAL AND FEMORAL-ARTERY BLOOD-FLOW IN CIRRHOSIS - RELATIONSHIP TO KIDNEY DYSFUNCTION [J]. HEPATOLOGY, 1993, 17 (05) : 788 - 793

[78] Mathie RT, 1996, HEPATOLOGY, V23, P130

[79] Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS:: Results of a prospective, randomized, controlled clinical trial [J]. LIVER TRANSPLANTATION, 2000, 6 (03) : 277 - 286

[80] ELEVATED CIRCULATING PLASMA ENDOTHELIN-1 CONCENTRATIONS IN CIRRHOSIS [J]. JOURNAL OF HEPATOLOGY, 1993, 19 (02) : 285 - 290